Lc3ltd
4 años hace
IntelGenx Ships First CBD Filmstrip Order to Heritage Cannabis
SAINT LAURENT, Quebec, March 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced that, further to its press releases of January 7 and March 25, 2021, it has completed its first shipment, consisting of 75,000 CBD Filmstrips, to Heritage Cannabis Holdings Corp. (“Heritage Cannabis”) (CSE:CANN).
The CBD Filmstrips were produced at IntelGenx’s manufacturing facility under Canadian GPP conditions and registered as a product for sale with Health Canada as a cannabis product governed by the Cannabis Act and with the Australian Department of Health’s Therapeutic Goods Administration as a medicinal cannabis product governed by the Narcotic Drugs Act.
Dr. Horst G. Zerbe, CEO of IntelGenx, commented, “This first-ever shipment from our Montreal facility of commercial quantities of an oral thin film product based on our VersaFilm® technology marks the achievement of another important milestone for our Company. We are looking forward to continuing to build a strong partnership with Heritage Cannabis, which shares our commitment to making innovative and high-quality oral thin film products available to medical cannabis consumers.”
“We are excited to introduce this innovative, rapid acting sublingual filmstrip CBD product that is based on proven pharmaceutical drug delivery technology into the Canadian and Australian markets,” commented Umar Syed, President of Medical Division at Heritage Cannabis. “We believe the future of the oral cannabinoid market will be dominated by products based on innovative technologies such as VersaFilm® that can deliver superior absorption and product performance.”
mc67
4 años hace
$IGXT DD (opinion) by Tim on Ya-00: Our Partner Heritage Cannabis: Heritage achieves Strong Sales Growth, Reaches First Million Dollar Revenues Week.
Heritage Cannabis Announces Closing of Public Offering for Gross Proceeds of $13,846,000.
Heritage Cannabis Announces Receipt of the First Health Canada Cannabis Export License Granted for Brazil. IntelGenx is currently manufacturing CBD oral film strips for Heritage Cannabis that is scheduled to be delivered in Q221.
Heritage will no doubt be debuting our films in Canada, USA, Australia and now Brazil real soon.
Heritage has been building-out several successful brands with a diversified line of attractively packaged and obviously well-selling CBD cannabis products.
Also: Don't forget that Tilray Owns 100% Exclusive World Wide Rights to IntelGenx' Immediate Release Precision Dosed THC Oral Film Strips (USPTO Patent Pending).
Keep in mind, I posted last week Aleafia's recent press release stating that their first month of 2021 saw dramatically increased sales with revenues surpassing all of their previous 4th quarters numbers PRIMARELY driven by strong sales of their Kin Slips THC Oral Film Strips.
All cylinders will be firing real soon in my opinion. IGXT up +166% in the last 6 months tells me more than just Peter Theil has been paying attention to us.
Things I would like to see on Monday or Tuesday morning:
1. IntelGenx Announces First THC Oral Film Strip Order from Tilray
or,
2. IntelGenx Announces First Rizaport Migraine Oral Film Strip Order from Excelsis
or,
3. IntelGenx Announces VetaFilm Partnership with Merck Animal Health, Novartis Animal Health, etc, etc.
As we all witnessed with last weeks dramatic news of ATAI's proposed equity stake, the news cycle is "heating-up". One only needs to refer to the 3 month and 6 month charts for illustration of that fact.
Great luck to all next week!!
GMA13
4 años hace
Very simply put, initially Atai Life Sciences will own around 25% of the IGXT, and with exercising all Options, etc. around 60%.
• IGXT gets 12.6Mil cash plus a Secured Loan option.
• IGXT gets another robust specialty pipe-line, with the synergistic advantages of coming-development.
IMO - For a Company like IGXT, this is a fantastic deal both financially & for future pure play specialty growth. You will see the PPS soar once the Market analysts weigh-in.
Reyeton
4 años hace
Got these Analyist reports at seeking alpha. The titles of these reports and the dates they were written say it all:
HORST NEEDS TO STEP DOWN IMMEDIATLY. HE HAS CLEARLY DEMONSTRATED HE IS NOT CAPABLE OF BRINGING THIS COMPANY FORWARD, IMO.
The marketplace is screaming for our technology, IMO.
Analysis:
IntelGenx: A Small Cap With A Big Pipeline In Cannabis, Alzheimer's, And ED
Danny Upshaw Wed, Sep. 26, 2018
IntelGenx- Maintaining Buy Rating
Singular Research Thu, Nov. 12, 2015
This Small Cap Is Poised To Tap Multi-Billion Dollar Migraine Treatment Market
Tedra DeSue Thu, Oct. 16, 2014
Intelgenx Leadership Change And CRL Response: Why I'm Still Bullish
Alexander Maxwell Mon, Aug. 04, 2014
IntelGenx: A Compelling Investment Opportunity
Alexander Maxwell Fri, Jun. 27, 2014
The Ducks Are Lining Up For IntelGenx Bulls
Scientist on Stocks Mon, Jan. 27, 2014
IntelGenx Technologies: A Small Cap Company With The Potential For Significant Gains
Alexander Maxwell Sun, Jan. 26, 2014
IntelGenx CEO Provides Insight Into The Company's Catalysts
Ben Yoffe Tue, Feb. 05, 2013
bUrRpPPP!
4 años hace
MASSIVE DILUTION NEWS OUT!
SAINT LAURENT, Quebec, May 28, 2020 -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Corporation”) today announced that it intends to issue shares of common stock (“Common Shares”) of the Corporation in payment of the outstanding $7,577,000 aggregate principal amount of the Corporation’s 8.00% convertible unsecured subordinated debentures due June 30, 2020 (the “Debentures”).
Under the terms of the trust indenture governing the Debentures (the “Indenture”), the Corporation has the option to satisfy its obligation to repay all or any portion of the principal amount of the Debentures outstanding by issuing and delivering Common Shares at a deemed price of 95% of the current market price (as defined in the Indenture) at the maturity date, subject to customary conditions set forth in the Indenture. The issuance of the Common Shares in repayment of the principal of the Debentures is subject to the acceptance by the TSX Venture Exchange (the “TSX-V”). The Common Shares issued in payment of interest on the Debentures will be issued pursuant to exemptions from the prospectus requirements of applicable securities laws.
The Corporation also announced today that a meeting of the holders of the Debentures (the “Meeting”) will be held on Thursday, June 25, 2020. Debentureholders as of the record date of May 28, 2020 will receive a notice and information circular in respect of the Meeting and information on how to attend the Meeting will be provided on the Corporation’s website in due course. As previously announced, the Corporation is proposing to amend the terms of the Debentures to extend the maturity date from June 30, 2020 to June 30, 2022 and reduce the conversion price from $1.35 to $0.50 (together, the “Proposed Amendments”). The Proposed Amendments, which have been conditionally approved by the TSX-V, remain subject to approval by the holders of not less than 66 2/3% of the outstanding principal amount of the Debentures represented at the Meeting. If debentureholder approval is obtained, the Corporation intends to proceed with the Proposed Amendments, including the extension of the maturity date, such that the intended repayment of principal in Common Shares on June 30, 2020 indicated above would no longer be required and would not occur.
The Debentures are listed on the TSX-V under the symbol “IGX.DB”.
Tasso9
5 años hace
Ask yourself this before buying. How many shares will management pick up at this low price. I've met management and board members during the past 3 annual meetings. The second to last the CEO had no clue what I was doing showing up at the main plant. I explained I was there for the annual meeting. I sensed there something was not right. The first annual meeting i sensed the ceo to be arrogant. Lasf years annual meeting was stocked with employees, and maybe 5 investors. I drilled the ceo about timelines, and failures. The ceo seemed deceptive in his usually soft spoken pretentious voice. I guarantee you they will not pick up any shares at this low price. If they do it will be a token, maybe ten thousand dollars worth, so to continue this false hope. The ceo has been running a deceptive shell game with their pipeline, my opinion.